Skip to main content

Day: December 17, 2020

Xebec Expands Product Portfolio and Enters German Hydrogen and Renewable Natural Gas Markets with Acquisition of Inmatec

– Acquisition fills product gaps in onsite Oxygen and Nitrogen generators for industrial and medical applications, and provides German sales and service network –ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE STATEDKey Transaction HighlightsExpanding industrial gas product portfolio and Cleantech Service Network with the acquisition of Inmatec, a German-based manufacturer of best-in-class onsite nitrogen and oxygen generatorsAcquiring leading oxygen and nitrogen generation technology with a reference base of over 8,000 installed systems worldwideIncreasing Cleantech Service Network coverage with parts of Europe, the Middle East and Africa through Inmatec’s existing service capabilitiesEntering the German hydrogen and renewable natural gas (RNG) markets, by leveraging Inmatec’s local sales and service teams to reach the country’s...

Continue reading

Xebec élargit son portefeuille de produits et fait son entrée sur les marchés de l’hydrogène et du gaz naturel renouvelable en Allemagne grâce à l’acquisition d’Inmatec

– Cette acquisition permet de combler une lacune dans les générateurs d’oxygène et d’azote sur place pour les applications industrielles et médicales et d’étendre notre réseau de ventes et de services en Allemagne –SAUF INDICATION CONTRAIRE, TOUS LES CHIFFRES SONT EXPRIMÉS EN DOLLARS CANADIENSFaits saillants de l’opérationExpansion du portefeuille de produits liés aux gaz industriels et du réseau de services de technologies propres grâce à l’acquisition d’Inmatec, société établie en Allemagne qui fabrique les meilleurs générateurs d’azote et d’oxygène sur place de leur catégorieAcquisition d’une technologie de production d’oxygène et d’azote de premier plan intégrée à plus de 8 000 systèmes installés à l’échelle mondialeExpansion du réseau de services de technologies propres dans certaines régions d’Europe, du Moyen-Orient...

Continue reading

Seacoast Banking Corporation of Florida Announces Share Repurchase Program

STUART, Fla., Dec. 17, 2020 (GLOBE NEWSWIRE) — Seacoast Banking Corporation of Florida (“Seacoast” or the “Company”) (NASDAQ: SBCF) announced that its Board of Directors (the “Board”) has adopted a share repurchase program. Under the repurchase program, which will expire on December 31, 2021, the Company may repurchase, from time to time, up to $100 million of its shares of common stock, representing approximately 6.1% of the Company’s outstanding common stock as of December 16, 2020.The repurchase program permits shares to be repurchased in the open market, by block purchase, in privately negotiated transactions, in one or more transactions from time to time, or pursuant to any trading plan adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 (the “Exchange Act”). Open market purchases...

Continue reading

Reunion Gold announces the inclusion of the NW Extension Project in Suriname in the Strategic Alliance with Barrick Gold and plans to conduct an airborne geophysical survey

LONGUEUIL, Quebec, Dec. 17, 2020 (GLOBE NEWSWIRE) — Reunion Gold Corporation (TSX-V: RGD) (the “Company”) is pleased to announce that Barrick Gold Corporation (“Barrick”) has opted to include the NW Extension Project in Suriname in the Strategic Alliance. The 925 square kilometres NW Extension Project area sits within the Northern Greenstone Belt of Suriname, 60 kilometres to the west-southwest of the capital, Paramaribo, and 70 km northwest of the Rosebel mine (Figure 1).The interpretation of available geophysical data indicates that the large, greenstone belt-scale geological structures associated with gold mineralization at the Rosebel gold deposit extend to the northwest under cover of recent sediments, underlying the project area footprint. To refine this observation and generate targets, the Alliance...

Continue reading

All American Equity Fund Merges with Global Luxury Goods Fund (USLUX)

San Antonio, TX, Dec. 17, 2020 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a boutique registered investment advisory firm with longstanding experience in global markets and specialized sectors, is pleased to announce that its All American Equity Fund will merge with the Global Luxury Goods Fund (USLUX). Shareholders approved the merger, which is expected to be reorganized on December 22, 2020.USLUX became the only U.S.-based mutual fund that focuses on the global luxury industry when it made its debut on July 1, 2020. The fund provides investors access to companies around the world that are involved in the design, manufacture and sale of products and services that are not considered to be essential but are highly desirable within a culture or society.“No doubt many people thought it inadvisable to...

Continue reading

Chembio Diagnostics Appoints David Acheson, M.D. to its Board of Directors

HAUPPAUGE, N.Y., Dec. 17, 2020 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Acheson, M.D. to the Company’s Board of Directors.“We are pleased to welcome David to our Board of Directors. He adds directly applicable expertise in public health and infectious disease management to our leadership team, and we are confident his perspective will contribute meaningfully to our long-term value creation strategy,” said Katherine L. Davis, Chair of Chembio’s Board of Directors. “We look forward to his leadership and insights as we enter the next phase of growth for Chembio.”Dr. David Acheson has served as the President and Chief Executive Officer of The Acheson Group since founding the global food safety...

Continue reading

Editas Medicine Names Meeta Chatterjee, Ph.D., to Board of Directors

CAMBRIDGE, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, today announced that it has appointed Meeta Chatterjee, Ph.D., to its Board of Directors.Dr. Chatterjee is an accomplished biopharmaceutical executive with more than 30 years of broad strategic and operational experience in research and development, mergers and acquisition evaluation, in-licensing, and externalization activities. She currently serves as Senior Vice President of Global Business Development at Legend Biotech where she provides oversight for all business development activities including prioritizing opportunities, managing evaluations, and executing transactions. She also leads Alliance Management activities at Legend. Prior to joining Legend, Dr. Chatterjee was Head of Strategy, Transactions,...

Continue reading

Steelcase Reports Third Quarter Fiscal 2021 Results

Revenue and orders continue to be significantly impacted by COVID-19 pandemicActions to reduce fixed costs and discretionary spending provided significant savings versus the prior yearLiquidity position remains very strong at $652 millionGRAND RAPIDS, Mich., Dec. 17, 2020 (GLOBE NEWSWIRE) — Steelcase Inc. (NYSE: SCS) today reported third quarter revenue of $617.5 million and net income of $2.1 million, or diluted earnings of $0.02 per share, which included $11.4 million of pre-tax restructuring costs related to previously announced workforce reductions. Excluding those charges, net of related income tax benefits, adjusted earnings were $0.08 per share. The results also reflected a delay of approximately $60 million of revenue to the fourth quarter due to a temporary global operations shutdown implemented to protect the company’s...

Continue reading

CareTrust REIT Announces Quarterly Dividend of $0.25 per Share; Strong Q4 Collections

SAN CLEMENTE, Calif., Dec. 17, 2020 (GLOBE NEWSWIRE) — CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that its Board of Directors has declared a quarterly common stock cash dividend of $0.25 per common share.Greg Stapley, CareTrust’s Chairman and Chief Executive Officer, reported that CareTrust collected 99.7% of its contractual cash rents for the fourth quarter. “Despite the ongoing COVID-19 pandemic, our outstanding tenants are finding ways to adapt and thrive,” he said. He noted that the company expects to pay the quarterly dividend on or about January 15, 2021, to common stockholders of record as of the close of business on December 31, 2020.About CareTrust REIT™CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled...

Continue reading

Correction: REVIUM RECOVERY ACQUIRES ANTI-ADDICTION REHABILITATION BUSINESS

OC Beverages changes name to “Revium Recovery, Inc.”, acquires new symbol and implements reverse stock splitNew York, Dec. 17, 2020 (GLOBE NEWSWIRE) — Revium Recovery, Inc. (OTCPINK: OCBGD) has, through its wholly owned subsidiary Revium Recovery, Ltd. (“Revium Ltd.”), acquired exclusive rights to develop and market an innovative and unique anti-addiction treatment which implements a proprietary measurement-based, integrative care approach. The focused method uses a holistic approach and takes into account physical, cognitive, and psychological parameters for each patient.  Addiction is a global scourge, affective people of all cultures around the world. According to the United Nations Office on Drugs and Crime, over 350 million people suffered from substance abuse in 2017. The global substance abuse disorders market is estimated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.